Related Experiment Video
Updated: Sep 2, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.3K
[Pulmonary manifestations in long COVID]
Natascha Sommer1, Bernd Schmeck2,3
1Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-Universität, Klinikstr. 33, 35390, Gießen, Deutschland. natascha.sommer@innere.med.uni-giessen.de.
Innere Medizin (Heidelberg, Germany)
|August 4, 2022
Summary
Pulmonary issues are common after SARS-CoV-2 infection, leading to long COVID syndrome. While symptoms and lung changes often improve, some patients need ongoing management for persistent respiratory problems.
Area of Science:
- Pulmonology
- Infectious Diseases
- Post-COVID Conditions
Background:
- Pulmonary manifestations are frequent complications following severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infections.
- These respiratory issues are commonly grouped under the umbrella term long COVID syndrome.
Purpose of the Study:
- To provide a comprehensive summary of the existing scientific literature concerning pulmonary manifestations in long COVID.
- To highlight expert opinions and current recommendations for managing these conditions.
Main Methods:
- Literature review focusing on pulmonary sequelae of SARS-CoV-2 infection.
- Inclusion of expert opinions and clinical recommendations.
- Analysis of diagnostic approaches and therapeutic strategies.
Main Results:
- Dyspnea is the most prevalent symptom in long COVID patients, following chronic fatigue.
- Radiological changes, interstitial lung disease characteristics, restrictive ventilation patterns, and diffusion capacity limitations are common findings, particularly after severe COVID-19.
- While pulmonary abnormalities tend to improve, some patients experience persistent issues months post-infection, with the exact causes and contributing factors remaining under investigation.
Conclusions:
- Knowledge regarding pulmonary manifestations in long COVID is continually evolving.
- A significant limitation exists due to the scarcity of clinical trials, precluding the development of evidence-based guidelines for diagnosis and therapy.
Keywords:
CoughDyspneaLong COVID/physiopathologyLung diseases, interstitialSevere acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)More Related Videos
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20COPD: Pathogenesis and Clinical Features
485
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
485
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:29Pneumonia II: Pathophysiology
465
The pathophysiology of pneumonia involves the following steps:
465
01:17Other Pulmonary Disorders
899
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
899
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K